Jump to Main Content

Programs

Special Interest Sessions

ASH Advances COVID Research 2021

Monday, December 13, 2021, 12:15 p.m. - 1:15 p.m.
Georgia World Congress Center, Hall C1

This session is designed to highlight the most significant submitted abstracts focused on COVID-19. Expert moderators will summarize the most important findings in three general areas of focus: (1) COVID-19 outcomes in hematology patients, (2) COVID-19-related thrombosis, and (3) COVID-19 immunology and vaccine responses. The presenting authors of the abstracts will take part in the live Q&A following each segment.

Speakers:

Lisa Baumann Kreuziger, MD
Versiti Blood Center of Wisconsin
Menomonee Falls, WI
Thrombosis in the Setting of COVID-19

Wendy Cozen, DO,MPH
USC Norris Comprehensive Cancer Center
Manhattan Beach, CA
Outcomes of COVID-19 Infection in Hematology Patients

Jeffery Auletta, MD
Nationwide Children's Hospital
Columbus, OH
Immunology and Immune Response to COVID-19 Vaccines

back to top

ASH Choosing Wisely® Campaign: 2021 ASH Choosing Wisely Champions

Monday, December 13, 2021, 12:15 p.m. - 1:15 p.m.
Georgia World Congress Center, A411-A412, Level 4

In cooperation with the ABIM Foundation, ASH has introduced the Choosing Wisely Champions initiative to recognize the efforts of practitioners who are working to eliminate costly and potentially harmful overuse of tests and procedures. Each year, three individuals are invited to present on successful utilization strategies that they have developed and implemented in their practice, institution, or hospital system. This provides an opportunity for clinicians, administrators, and other medical professionals to learn about projects that might be translated to their own practices.

Speakers:

Thomas Bodley, MD
Sunnybrook Health Sciences Center
Toronto, ON, Canada
Reducing Repetitive Diagnostic Phlebotomy in an Intensive Care Unit: A Quality Improvement Project

Srila Gopal, MD
University of California San Diego
La Jolla, CA
Establishing Same Day Infusion Treatment Protocols for Uncomplicated Sickle Cell Vaso-Occlusive Crises Utilizing a Telemedicine Platform

Matthew Tenison McEvoy, MD
Texas Children's Hospital
Houston, TX
Practice Standard for Management of Nutritional Iron Deficiency Anemia in the Emergency Department: A Quality Improvement

back to top

ASH Foundation Run/Walk

Sunday, December 12, 2021, 7:00 a.m. - 9:00 a.m.
Centennial Olympic Park, Park Avenue West

Start your day in a healthy, fun, and philanthropic way by participating in the eighth annual ASH Foundation Run/Walk before attending sessions on December 12. Participants may run or walk through the designed course through scenic downtown Atlanta, choosing a 3K or 5K route. Not attending the meeting in-person? Don't worry; you too can participate virtually. Proceeds from all individual and group registration fees and individual donations benefit ASH's Minority Recruitment Initiative Fund and Career Development and Training Fund.

back to top

ASH Health Equity Rounds Lunch

Stigma and Bias in Sickle Cell Disease

Sunday, December 12, 2021, 11:30 a.m. - 12:30 p.m.
Omni Atlanta Hotel at CNN Center, Grand Ballroom D2-E, M4/Grand Ballroom Level

Health Equity Rounds are interactive, case-based discussions with an interdisciplinary panel to include hematologists, health equity/public health experts, patients, and patient advocates to discuss health equity issues within hematology. Lunch will be provided to in-person attendees. Virtual participants welcome!

Health Equity Rounds Goals and Objectives:

  1. Create a longitudinal, bi-directional clinical case-based series to encourage providers to recognize and explore the impact of implicit bias and systemic racism on patients with hematologic conditions
  2. To inspire participants to engage at the individual, community, and institutional level to address and mitigate bias and systemic racism
  3. To provide solutions/tools to enhance providers’ confidence in their abilities to decrease the impact of implicit bias at the individual, community, and institutional levels

The pilot series will kick-off with a 60-minute in-person session at the 2021 ASH Annual Meeting. Following the meeting, a series of bi-monthly webinars will be conducted focusing on various disease cases and provocative health equity topics. The series will include interactive and engaging techniques through experiential learning, breakout sessions, and interactive lectures. The pilot series will conclude with an in-person meeting at the 2022 ASH Annual Meeting.

Moderators:

Anjlee Mahajan, MD
UC Davis Comprehensive Cancer Center
Sacramento, CA

Lachelle D. Weeks, MD,PhD
Dana Farber Cancer Institute
Boston, MA

Ahmar Urooj Zaidi, MD
Detroit Medical Center
Detroit, MI

back to top

ASH Networking Reception for the Hemostasis and Thrombosis Community (for in-person participants)

Monday, December 13, 2021, 6:30 p.m. - 7:30 p.m.
Omni Atlanta Hotel at CNN Center, International Ballroom A-C, M2/International Ballroom Level

This reception immediately follows the Special Symposium on the Basic Science of Hemostasis and Thrombosis and is a chance to network with colleagues from the hemostasis and thrombosis community.  Clinicians and researchers are encouraged to attend.

This reception is also an opportunity to meet and mingle with ASH Vice President Dr. Robert Brodsky.

back to top

ASH Practice Partnership Lunch Program - How COVID-19 Changed the Practice Model

Sunday, December 12, 2021, 11:15 a.m. - 12:30 p.m.
Omni Atlanta Hotel at CNN Center, International Ballroom A-D, M2/International Ballroom Level

Currently, the United States and countries around the world face a major public health crisis with the outbreak of the novel coronavirus (COVID-19). This virus has led to sweeping changes in how hematologists provide care and how patients access it. While there have been learning pains, the pandemic offers possibilities of change and reform that could improve the medical community’s ability to serve the hematologic needs of patients. COVID-19 has exposed failings in the health care system in the inequality of treatment but has also offered chances to expand accessibility to services.

Scheduled at the ASH Annual Meeting and virtually, panelists will speak on opportunities for practices to expand telehealth services and focus on recruitment and retention efforts; lessons learned on disparities in hematology and developing new delivery points of care; and exploring the changing methods of teaching fellows and residents and the use of continuing medical education for hematologists in practice.

Speakers:

Michael D Tarantino, MD
Bleeding and Clotting Disorders Insitute
Peoria, IL
Opportunities for Practices to Expand Telehealth Services and Focus on Recruitment and Retention Efforts

Christopher R. Flowers
MD Anderson Cancer Center
Houston, TX
Lessons Learned on Disparities and Developing New Delivery Points of Care

Jennifer Green, MD
Vanderbilt University Medical Center
Nashville, TN
Exploring the Changing Methods of Training Fellows and Residents and the Use of CME for Hematologists in Practice

back to top

ASH-FDA Joint Symposium on Newly Approved Drugs: Treatment Advances in Rare Diseases

Monday, December 13, 2021, 4:30 p.m. - 6:00 p.m.
Georgia World Congress Center, Hall C2-C3

Speakers:

Tanya Wroblewski, MD
U.S. Food and Drug Administration
Silver Spring, MD
Introduction

Julie Weisman
U.S. Food and Drug Administration
Silver Spring, MD
Treatment Landscape of Paroxysmal Nocturnal Hemoglobinuria - Complement Inhibitors: Pegcetacoplan

Robert Brodsky, MD
Johns Hopkins University
Baltimore, MD
Treatment Landscape of Paroxysmal Nocturnal Hemoglobinuria - Clinical Discussant

Andrew Dmytrijuk, MD
U.S. Food and Drug Administration
Silver Spring, MD
Treatment Landscape of Systemic Mastocytosis and Mast Cell Leukemia: Avapritinib

Jason Gotlib, MD, MS
Stanford Cancer Center
Palo Alto, CA
Treatment Landscape of Systemic Mastocytosis and Mast Cell Leukemia - Clinical Discussant

Carrie Diamond, MD
U.S. Food and Drug Administration
Silver Spring, MD
Treatment Landscape for Pediatrics Anticoagulation: Approach to Development for Pediatric DOACs

Fadi Nossair, MD,MSc
U.S. Food and Drug Administration
Silver Spring, MD
Treatment Landscape for Pediatrics Anticoagulation: Dabigatran etexilate

Sarah H. O'Brien, MD
Nationwide Children's Hosptial
Columbus, OH
Treatment Landscape for Pediatrics Anticoagulation - Clinical Discussant

Rachel Ershler, MD
US FDA
Silver Spring, MD
Treatment Landscape for AL Amyloidosis: Daratumumab plus hyaluronidase

Vaishali Sanchorawala, MD
Boston Medical Center Corporation
Boston, MA
Treatment Landscape for AL Amyloidosis - Clinical Discussant

back to top

ASH-FDA Joint Symposium on Newly Approved Drugs: Treatment Landscape in the Era of Novel Therapies

Monday, December 13, 2021, 10:30 a.m. - 12:00 p.m.
Georgia World Congress Center, Hall C2-C3

Speakers:

Bindu Kanapuru, MD
U.S. Food and Drug Administration
Vienna, VA
Introduction

Andrea C. Baines, MD, PhD
U.S. Food and Drug Administration
Silver Spring, MD
Treatment landscape MM-BCMA - Antibody Drug Conjugate: Belantamab mafodotin

Poornima Sharma, MD
U.S. Food and Drug Administration
Silver Spring, MD
Treatment landscape MM-BCMA - CAR T Therapy: Idecabtagene vicleucel

Eric L. Smith, MD,PhD
Dana-Farber Cancer Institute
Boston, 
Treatment landscape MM-BCMA - Clinical Discussant

Maryam Sarraf Yazdy, MD
U.S. Food and Drug Administration
Washington, DC
Expanding the Treatment Landscape for Follicular Lymphomas: Umbralisib and Tazemetostat

Sonali M. Smith, MD
University of Chicago
Chicago, IL
Expanding the Treatment Landscape for Follicular Lymphomas – Clinical Discussant

Gulsum E Pamuk, MD
U.S. Food and Drug Administration
Silver Spring, MD
Treatment Landscape of Chronic Myeloid Leukemia: Asciminib

Ravi Bhatia, MD
University of Alabama at Birmingham
Birmingham, AL
Treatment Landscape of Chronic Myeloid Leukemia - Clinical Discussant

Najat Bouchkouj, MD
U.S. Food and Drug Administration
Silver Spring, MD
Treatment landscape for Treatment of Relapsed/Refractory Adult Acute Lymphoblastic Leukemia - CAR T Therapy: Brexucabtagene autoleucel

Richard A. Larson, MD
University of Chicago
Chicago, IL
Treatment landscape for Treatment of Relapsed/Refractory Adult Acute Lymphoblastic Leukemia - Clinical Discussant

back to top

Blood and Beyond

Sunday, December 12, 2021, 4:30 p.m. - 6:00 p.m.
Georgia World Congress Center, Sidney Marcus Auditorium, Level 4

Scientifically and clinically, the study of blood commands a professional engagement that can lead hematologists to lose sight of the complex notions held by the non-medical world. The editors of the Blood journal take the opportunity to highlight the intersection of hematology and humanities by bringing to light the epic story of blood, the care of patients, and the role that Blood has played in the advancement of the new hematologic discoveries in the educational session, Blood and Beyond, chaired by Dr. Nancy Berliner, Editor-in-Chief of the Blood journal.

This year’s speaker will be Dr. Paul Farmer. American medical anthropologist and physician. Dr. Farmer holds an MD and PhD from Harvard University, where he is the Kolokotrones University Professor and the chair of the Department of Global Health and Social Medicine at Harvard Medical School. He is co-founder and chief strategist of Partners In Health (PIH), an international non-profit organization that since 1987 has provided direct health care services and undertaken research and advocacy activities on behalf of those who are sick and living in poverty. He is professor of medicine and chief of the Division of Global Health Equity at Brigham and Women’s Hospital.

He will speak on “Irrigating the Clinical Desert: Clinical and Laboratory Services and Medical Emergencies: An infectious disease doctor reflects on introducing and strengthening basic clinical and laboratory services during epidemic Ebola in West Africa and in response to earthquakes in Haiti.”

Dr. Joia Mukherjee will join Dr. Berliner for Q&A.

Speaker:

Paul Farmer, MD,PhD
Harvard Medical School
Boston, MA
Irrigating the Clinical Desert: Clinical and Laboratory Services and Medical Emergencies

back to top

DEI Community Networking Lunch (for in-person participants)

Sunday, December 12, 2021, 12:30 p.m. - 1:30 p.m.
Omni Atlanta Hotel at CNN Center, Grand Ballroom C, M4/Grand Ballroom Level

This luncheon is an informal community-building and networking event for conference attendees who are members of the richly-diverse communities within hematology. The event is hosted by the ASH Committee on Promoting Diversity and aims to create a sense of belonging and allyship and where possible identify opportunities to learn more about the experiences and needs of these communities to allow us to have a greater impact in our efforts to dismantle bias and barriers.

back to top

Gene Editing and Real-World Data: A New Generation for Real-World Evidence

Monday, December 13, 2021, 4:30 p.m. - 5:30 p.m.
Georgia World Congress Center, C208-C210, Level 2

This session will review the role of real world evidence in support sickle cell disease gene editing research. Perspectives from FDA will be presented, in addition to findings from an ongoing collaborative multistakeholder project hosted by the ASH Research Collaborative and the Innovative Genomics Institute.

Speakers:

William A. Wood, MD,MPH
University of North Carolina
Chapel Hill, NC
Real World Evidence Initiative for Sickle Cell Disease Gene Editing Research: Stakeholders Working Together

Peter W. Marks, MD, PhD
FDA
Washington, DC
Opportunities for Use of Real-World Evidence to Support Regulatory Decision Making

Donna S. Neuberg, ScD
DFCI
Los Angeles, CA
Genomic Therapies Work Group: Report and Recommendations

Jane S Hankins, MD, MS
St. Jude Children's Research Hospital
Memphis, TN
Coordinated Registry Network Work Group: Report and Recommendations

Fyodor D Urnov, PhD
Innovative Genomics Institute
Berkeley, CA
Next Steps

back to top

Grassroots Network Lunch

A Discussion with Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention

Saturday, December 11, 2021, 11:15 a.m. - 12:15 p.m.
Omni Atlanta Hotel at CNN Center, International Ballroom A-D, M2/International Ballroom Level

The ASH Grassroots Network Lunch provides a forum for interested members to learn how they can participate in ASH’s advocacy efforts, communicate with Congress, become effective advocates for hematology, and discuss the Society’s legislative and regulatory priorities. The keynote speaker for this year's Grassroots Network Lunch will be Rochelle Walensky, MD, MPH, the Director of the Centers for Disease Control and Prevention. Dr. Walensky will discuss efforts by the CDC to both highlight and address health disparities and racism as a threat to the nation's health as well as the important role hematologists can play in furthering this goal.

Speaker:

Rochelle Walensky, MD, MPH
Centers For Disease Control and Prevention
Atlanta, GA
CDC's Efforts to Address Health Disparity as a Threat to the Nation's Health

back to top

How to Get Published in a Peer-Reviewed Journal

Saturday, December 11, 2021, 11:15 a.m. - 12:15 p.m.
Georgia World Congress Center, C108-C109, Level 1

back to top

How to Peer Review a Scientific Paper

Sunday, December 12, 2021, 11:15 a.m. - 12:15 p.m.
Georgia World Congress Center, C202-C204, Level 2

back to top

Medical Educators Symposium

Sunday, December 12, 2021, 7:30 a.m. - 9:30 a.m.
Omni Atlanta Hotel at CNN Center, Grand Ballroom A-B, M4/Grand Ballroom Level

The Medical Educators Symposium (previously called the Hematology Course Directors Workshop) is open to all medical educators across the medical student, resident, and fellow continuum. The Medical Educators Symposium highlights cutting edge teaching techniques and theories while also showcasing participants of the ASH Medical Educators Institute. The symposium is two hours long and will begin with a general session focused on medical education principles.

Speakers:

Ariela L. Marshall, MD
Mayo Clinic
Rochester, MN
Tips for Effective Feedback for Millennials

Leslie Renee Ellis, MD, MSHPEd
Wake Forest Baptist Health Comprehensive Cancer Center
Winston-Salem, NC
Burnout

Teresa Scordino, MD
University of Oklahoma College of Medicine
Oklahoma City, OK
ASH MEI Participant Project Highlight on Technology and Medical Education

Leslie Segal Kersun, MD, MSEd
Children's Hospital of Philadelphia
Philadelphia, PA
Breakout #1: How to Develop Effective Small Group Teaching Sessions

Martina C Murphy, MD
UF Hematology/Oncology
Gainesville, FL
Breakout #1: How to Develop Effective Small Group Teaching Sessions

Aaron T. Gerds, MD,MS
Cleveland Clinic Taussig Cancer Institute
Cleveland, OH
Breakout #2: Use of Twitter in Hematology

Marc J. Kahn, MD, MBA
Tulane University
Las Vegas, NV
Breakout #3: How to be a Good Mentor

Ted Wun, MD
University of California Davis School of Medicine
Sacramento, CA
Breakout #3: How to be a Good Mentor

back to top

Meet the Blood Editors (for in-person participants)

Sunday, December 12, 2021, 11:15 a.m. - 12:15 p.m.
Georgia World Congress Center, A305, Level 3

These sessions provide the opportunity for attendees to meet with the associate editors of Blood and discuss recent changes to the journal as well as submission and peer-review processes and policies, with each session giving a unique focus. Seating is limited and available on a first-come, first-served basis.

back to top

Promoting Minorities in Hematology Oral Presentations Room I

Saturday, December 11, 2021, 6:30 p.m. - 9:00 p.m.
Omni Atlanta Hotel at CNN Center, Grand Ballroom ABC, M4/Grand Ballroom Level

Speakers:

Bria K Carrithers, MD
Medical College of Georgia
Albany, GA
Knowledge of Fertility and Perception of Fertility Treatment Among Adults with Sickle Cell Disease (KNOW FERTILITY)

Chinonso Michelle Ukeje, MD
University of Illinois at Chicago
Chicago, IL
The Burden of Atrial Fibrillation in Sickle Cell Disease

Christina Onyebuchi
University of Texas Medical Branch
San Antonio, TX
Subanesthetic Ketamine in the Management of Pain in Sickle Cell Disease Patients: A Retrospective Analysis

Michael Rabaza, BS
University of Illinois at Chicago
Chicago, 
Clinical and Biomarker Predictors for Avascular Necrosis in Sickle Cell Disease

Miriam Kwarteng-Siaw, MD
Brigham and Women's Hospital
Boston, MA
Morbidity and Mortality Associated with Hemodialysis (HD) Versus Peritoneal Dialysis (PD) in Patients with End Stage Renal Disease Caused By Sickle Cell Disease (SCD-ESRD)

SaRah R. McNeely, MS
Florida Atlantic University Schmidt College of Medicine
Boca Raton, FL
Functional Connectivity in Pediatric Sickle Cell Disease

Trish Ike, BA
MCW
Milwaukee, 
Investigating the Association between Inflammatory Diet and Pain in Individuals with Sickle Cell Disease

Ugochukwu Agbakwuru
Washington University School of Medicine in St. Louis
Saint Louis, MO
Implementation of an Intravenous Lidocaine Guideline for Children and Adolescents with Sickle Cell Vaso-Occlusive Pain

back to top

Promoting Minorities in Hematology Oral Presentations Room II

Saturday, December 11, 2021, 6:30 p.m. - 9:00 p.m.
Omni Atlanta Hotel at CNN Center, Grand Ballroom D1/D2

Speakers:

Beatrice Razzo, MD
NYU Langone Health
New-York, NY
Clinical and Biological Factors That Affect Presentation and Outcomes in Multiple Myeloma Patients with Excess Body Weight

Dalina Laffita
FLORIDA ATLANTIC UNIVERSITY
Boca Raton, 
Evaluation of Low Dose Radiation Therapy Alongside CAR T Cell Therapy As a Therapeutic Treatment for Hematological Cancers

Guido David Pelaez
George Washington University
Washington, DC
Evaluation of Selective HDAC6 Inhibition As a Potentiator of Antigen-Targeted Immunotherapy in Diffuse Large B-Cell Lymphoma

Gygeria Manuel
MOREHOUSE SCHOOL OF MEDICINE
Conyers, GA
Understanding Barriers to Clinical Trial Enrollment for African American Patients with Lymphoma

Mohammad Abubakar
Lincoln Memorial
Harrogate, 
Targeting U5 snRNP200 for Acute Myeloid Leukemia Therapy

Rigoberto De Jesus Pizarro, MD
University of Texas Health Science Center at San Antonio
San Antonio, 
Roots of Socioeconomic and Biological Disparities Among Hispanics with Multiple Myeloma

Sarah Addison, BS
Ohio State College of Medicine
Columbus, 
Identifying Disparities in Survival Among Older Adults with Multiple Myeloma Based on Rural Versus Urban Residence

back to top

Promoting Minorities in Hematology Oral Presentations Room III

Saturday, December 11, 2021, 6:30 p.m. - 9:00 p.m.
Omni Atlanta Hotel at CNN Center, Grand Ballroom E, M4/Grand Ballroom Level

Speakers:

Alfonso Molina, MD, MPH
Stanford University School of Medicine
Stanford, CA
Epidemiologic Evaluation of Clinical Outcomes in Ethnic Minorities with Myelodysplastic Syndrome

Maryam Omar, BS
Mayo Clinic Alix School of Medicine
Rochester, MN
Interleukin-6 Levels and Disease Activity in POEMS Syndrome

Mwanasha H. Merrill, MD
Dana Farber Cancer Institute
Boston, MA
Outcomes of Mature T-Cell and NK/T-Cell Lymphomas in Patients with and without HIV: Results from NA-Accord and Complete.

Oluwamayokun Oshinowo, BS
Medical College of Georgia
Lagrange, GA
Defining the Mechanism for Impaired Platelet Forces in Immune Thrombocytopenia

Orly Leiva, MD
New York University Langone Health
New York, NY
Cardiovascular Outcomes in Patients with Myeloproliferative Neoplasms

Uzoamaka Obodo
Lincoln Memorial
Harrogate, TN
Exploratory Analysis of the Association between Environmental Exposures to Toxins and Acute SCD Hospitalizations

back to top

Promoting Minorities in Hematology Reception

Saturday, December 11, 2021, 8:00 p.m. - 9:00 p.m.
Omni Atlanta Hotel at CNN Center, Grand Ballroom Foyer, M4/Grand Ballroom Level

back to top

Special Education Session on ASH Clinical Practice Guidelines on Acute Myeloid Leukemia in Older Adults

Monday, December 13, 2021, 4:30 p.m. - 6:00 p.m.
Georgia World Congress Center, Thomas Murphy Ballroom 1-2, Level 5

In 2017 ASH initiated its first guideline development effort on a malignant topic: acute myeloid leukemia in older adults. This topic was selected as clinically important and largely unaddressed by existing guidelines. Development of these guidelines, including systematic evidence review, was supported by the McMaster University GRADE Centre. The guidelines were published in Blood Advances on August 6, 2020.

In this special session, speakers will highlight particularly notable recommendations and will discuss important considerations for the practical application of the recommendations in practice. 

Speakers:

Christopher S. Hourigan, DM DPhil
NHLBI
Bethesda, MD
Epidemiology and Clinical Risk Factors for AML Outcome in Older Adults

Jessica K. Altman, MD
Northwestern University Feinberg School of Medicine
Chicago, IL
Intensive Vs. Less-Intensive Induction Therapy (and in which category should we place venetoclax combinations?)

Pinkal Desai, MD,MPH
Weill Cornell Medical College
New York, NY
So You’Re in a Remission. Now What?

Thomas W. LeBlanc, MD,MA,MS
Duke university hospital
Hillsborough, NC
Supportive Care during Active Therapy and during Active Palliation

back to top

Special Education Session on ASH Clinical Practice Guidelines on Sickle Cell Disease

Monday, December 13, 2021, 10:30 a.m. - 12:00 p.m.
Georgia World Congress Center, C108-C109, Level 1

In 2016, ASH initiated the development of five clinical practice guidelines on sickle cell disease, addressing acute and chronic complications of the disease as well as stem cell transplantation. These first four guidelines, on cardiopulmonary and kidney Disease, transfusion support, cerebrovascular disease, and acute and chronic pain have been published in Blood Advances, with the remaining stem cell transplantation chapter scheduled for publication in 2021.

In this special session, speakers will highlight particularly notable recommendations from the SCD guidelines and will discuss important considerations for the practical application of the recommendations in practice, including a focus on dissemination and implementation strategies. 

Speakers:

Ted Wun, MD
University of California Davis School of Medicine
Sacramento, CA
Policy Shaping and Quality Metrics

John J. Strouse, MD
Duke University School of Medicine
Durham, NC
Patient Versions

Ifeyinwa (IFY) Osunkwo, MD, MPH
Sickle Cell Disease Enterprise at The Levine Cancer Institute/Atrium Health
Charlotte, NC
Dissemination and Implementation

back to top

Special Education Session on ASH Clinical Practice Guidelines on Venous Thromboembolism

Monday, December 13, 2021, 2:45 p.m. - 4:15 p.m.
Georgia World Congress Center, B207-B208, Level 2

Ten ASH clinical practice guidelines on VTE have been published in Blood Advances, and two others are planned for submission to Blood Advances in 2021 (thrombophilia testing and a special adaption of the VTE guidelines for Latin America).

In this special session, speakers will highlight particularly notable recommendations from the VTE guidelines and will discuss important considerations for the practical application of the recommendations in practice, including a focus on dissemination and implementation strategies and on the rapid development of COVID-19 guidelines on anticoagulation.

Speakers:

Kristen M. Sanfilippo, MD
Washington University in St. Louis School of Medicine
Chesterfield, MO
COVID-19 and VTE

Saskia Middeldorp, MD,PhD
Academic Medical Center
Nijmegen, Netherlands
Thrombophilia

Ignacio Neumann, MD,PhD
Pontificia Universidad Católica
Santiago, CHL
VTE in Latin America

back to top

Special Education Session on ASH Clinical Practice Guidelines on von Willebrand Disease

Monday, December 13, 2021, 4:30 p.m. - 6:00 p.m.
Georgia World Congress Center, B207-B208, Level 2

The American Society of Hematology collaborated with the International Society on Thrombosis and Haemostasis, National Hemophilia Foundation, World Federation of Hemophilia, and Kansas University Medical Center to develop clinical practice guidelines on the diagnosis and management of von Willebrand Disease (VWD). These guidelines were published in January of 2021.

In this special session, speakers will highlight particularly notable recommendations and will discuss important considerations for the practical application of the recommendations in practice.

Speakers:

Michelle Lavin, MB, PhD, FRCPath
Royal College of Surgeons in Ireland
Dublin 2, Ireland
Management of VWD

Peter A. Kouides, MD
University of Rochester
Rochester, NY
Management of VWD

Robert F. Sidonio Jr., MD, MSc
Emory University
Atlanta, GA
Diagnosis of VWD

back to top

Special Education Session on Collaborative Hematology Networks

Monday, December 13, 2021, 2:45 p.m. - 3:30 p.m.
Georgia World Congress Center, B211-B212, Level 2

Clinical research, especially randomized controlled trials (RCT), require collaboration. Advantages of multicenter clinical research are faster study completion and greater generalizability of results. Clinical research networks allow experts to conduct multiple studies around the same disease state. The session will explore three recently developed clinical trial networks focused on hematologic diseases.

Dr. Charles Abrams will discuss the ASH Research Collaborative Data Hub and Sickle Cell Disease Clinical Trials Network (SCD-CTN) which is composed of highly vetted & engaged clinical trial sites, a database of well characterized patients, and advisory boards for scientific and community review. Foundational to the SCD-CTN is community engagement. The SCD-CTN is uniquely positioned to accelerate development and approval of novel therapy to improve the quality of life for those living with sickle cell disease.

The H. Jean Khoury Cure CML Consortium (HJKC3) is named after the late Dr. H. Jean Khoury who had a vision to improve the care of patients with CML through collaboration. The HJKC3 is a group of researchers from 19 world-class academic medical centers throughout North America committed to curing CML through innovative research. In this talk, Dr. Ehab Atallah will discuss how the HJKC3 was established, current activities and future directions.

Dr. Baumann Kreuziger will discuss the Venous thromboembolism Network United States (VENUS), a research network composed of investigators from 38 states whose mission is to develop and conduct clinical trials and research about thrombosis. She will discuss the network development, lessons learned, and how COVID-19 affected the network.

back to top

Special Interest Session on Systems-Based Hematology

patient blood management

Sunday, December 12, 2021, 4:30 p.m. - 6:30 p.m.
Georgia World Congress Center, C108-C109, Level 1

This session will again focus on the role, importance, and value of the systems based hematologist to the health care system. The focus of this years session will be on patient blood management (PBM). The first session will highlight the development and implementation of a pre-operative anemia clinic. The second session will focus on the development, implementation, as well as support needed in developing an overall PBM program. Both of these sessions will spotlight the role of the hematologist in the success of a PBM program.

Speakers:

Marc Zumberg, MD
University of Florida
Gainesville, FL
An Introduction to Systems-Based Hematology

Colleen Morton, MD
Vanderbilt
Nashville, TN
How I Set Up a Perioperative Blood Management and Preoperative Anemia Evaluation Program-Preoperative Phase

Bruce Spiess
University of Florida College of Medicine
Gainesville, FL
How I Set Up a Bloodless Medicine Program

back to top

Special Scientific Session on Race and Science

Saturday, December 11, 2021, 4:00 p.m. - 4:45 p.m.
Georgia World Congress Center, Hall C2-C3

back to top

Special Symposium on Quality: Identifying and Eliminating Inequity in the Provision of Healthcare

Saturday, December 11, 2021, 2:00 p.m. - 3:30 p.m.
Georgia World Congress Center, Hall C2-C3

This year's Special Symposium on Quality will focus on examining how systemic inequities impact healthcare quality, and what hematologists can do to promote more equitable provision of healthcare.  The session will include practical examples of the negative impact of inequity on the quality of care patients receive, proven mechanisms for effectuating meaningful change in health equity and outcomes, and a keynote address on the social and moral determinants of health.  The session will conclude with Q&A and a call-to-action for attendees to pursue their own quality improvement projects that address issues related to equity and/or implicit bias.

Speakers:

Maureen Okam Okam Achebe, MD,MPH
Hematology Division Brigham and Women's
Boston, MA
Equity in Patient Care and Outcomes

Lanetta Bronte-Hall, MD, MPH, MSPH
Foundation for Sickle Cell Disease Research
Hollywood, FL
Mechanisms for Change in Health Equity

Kara Odom Walker, MD,MPH
Nemours Children's Health
Washington, DC
The Social and Moral Determinants of Health / Equity in Healthcare

back to top

The Role of Real World Data Collection in Hematologic Malignancies

Sunday, December 12, 2021, 4:30 p.m. - 6:00 p.m.
Georgia World Congress Center, B312-B314

Speakers:

Martin S. Tallman, MD
Memorial Sloan-Kettering Cancer Center
New York, NY
The Role of Real-World Data in Hematologic Malignancy Research (ASH Research Collaborative)

John Gribben, MD, DSc, FRCP, FRCPath, FMedSci
Barts Cancer Institute, Barts and The London School of Medicine, Queen Mary, University of London
London, United Kingdom
Role of Real-World Data in Hematologic Malignancy Research (HARMONY)

William A. Wood, MD,MPH
University of North Carolina
Chapel Hill, NC
Real-World Data Expectations, Challenges, and Potential Solutions to Accelerate Research (ASH Research Collaborative)

Guillermo Sanz, MD,PhD
HARMONY Alliance Co-Chair
Valencia, Spain
Real-World Data Expectations, Challenges, and Potential Solutions to Accelerate Research (HARMONY)

Nicole J. Gormley, MD
U.S. Food and Drug Administration
Bethesda, MD
Regulatory Perspective on Data sharing and Real-World Data to Generate Real-World Evidence

Jan Geissler
Leukanet / representing the HARMONY Alliance Patient Cluster
Riemerling, Germany
Patient's Viewpoint on Real World Data Sharing

Kenneth C. Anderson, MD
Dana-farber/Boston Children's Cancer and Blood Disorders Ctr
Boston, MA
Multiple Myeloma Real World Data for Research (ASH Research Collaborative)

Mario Boccadoro
Cattedra Ematologia
Torino, Italy
Multiple Myeloma Real-World Data for Research (HARMONY)

Laura C. Michaelis, MD
The Medical College of Wisconsin Inc.
Milwaukee, WI
Acute Myeloid Leukemia Real World Data for Research (ASH Research Collaborative)

Lars Bullinger
Charite University Berlin
Berlin, Germany
Acute Myeloid Leukemia Real World Data for Research (HARMONY)

Jesus Maria Hernández-Rivas, MD PhD
HARMONY Alliance Chair
Salamanca, Spain
Conclusion

back to top

Training Program Directors' Workshop

Mentorship and Career Development

Friday, December 10, 2021, 9:00 a.m. - 12:00 p.m.
Omni Atlanta Hotel at CNN Center, International Ballroom B-C, M2/International Ballroom Level

The Training Program Directors Workshop is held each year before the ASH annual meeting and is designed for training program directors, associate program directors, and others involved with hematology training to share lessons learned, best practices, and explore opportunities to improve their leadership skills. Through experiential learning techniques, breakout sessions, and interactive lectures, program directors can learn from peers and build their network.

Speakers:

Grzegorz S. Nowakowski, MD
Mayo Clinic
Rochester, MN
Working Breakfast: ASH-Industry Sponsored Clinical Trial Fellowship

Alice Ma, MD
University of North Carolina At Chapel Hill
Chapel Hill, NC
Mentorship?and Career Development

Leslie Segal Kersun, MD, MSEd
Children's Hospital of Philadelphia
Philadelphia, PA
Mentorship?and Career Development

Michael Linenberger, MD
University of Washington
Seattle, WA
Well-Being and Resilience

Kenneth Adler, MD
Summit Medical Group
Florham Park, NJ
Well-Being and Resilience

Martha L. Arellano, MD
Emory University School of Medicine
Atlanta, GA
Recruitment and Retention

Rakhi P. Naik, MD, MHS
Johns Hopkins University
Baltimore, MD
Recruitment and Retention